Published in Schizophr Res on May 02, 2007
Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry (2015) 3.56
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol (2011) 2.15
Antipsychotic drugs and obesity. Trends Mol Med (2010) 1.21
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. Ther Adv Psychopharmacol (2014) 1.15
Management of antipsychotic-related weight gain. Expert Rev Neurother (2010) 1.07
Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One (2014) 1.02
Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease. Diabetes (2013) 1.01
Addressing cardiometabolic risk during treatment with antipsychotic medications. Curr Opin Psychiatry (2008) 0.88
Association of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study). Front Genet (2011) 0.82
Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications. Pharmacogenomics (2011) 0.79
A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK population. J Nutr Sci (2015) 0.75
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurol Ther (2016) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
Obesity and the metabolic syndrome in children and adolescents. N Engl J Med (2004) 13.99
Overweight, obesity, and health risk. Arch Intern Med (2000) 5.22
The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl (1989) 4.53
Socioeconomic status and weight change in adults: a review. Soc Sci Med (2004) 3.57
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
The unhealthy lifestyle of people with schizophrenia. Psychol Med (1999) 3.54
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry (1999) 3.48
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol (2006) 3.11
Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res (2000) 2.88
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry (2000) 2.41
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry (2005) 2.39
Midlife body mass index and hospitalization and mortality in older age. JAMA (2006) 2.36
Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology (2003) 1.96
Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J Am Acad Child Adolesc Psychiatry (2002) 1.75
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry (2005) 1.68
The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry (1999) 1.67
Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand (2002) 1.60
Weight gain associated with antipsychotic drugs. J Clin Psychiatry (1999) 1.51
Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. Arch Gen Psychiatry (1991) 1.42
Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull (2003) 1.28
The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res (2005) 1.28
Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci (2002) 1.25
Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol (2004) 1.22
Are older antipsychotic drugs obsolete? BMJ (2006) 1.19
Methods for assessing positive and negative symptoms. Mod Probl Pharmacopsychiatry (1990) 1.18
Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States. Arch Gen Psychiatry (2003) 1.13
Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry (2001) 1.12
Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophr Res (2002) 1.11
Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis. J Clin Psychiatry (1996) 1.10
Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr Res (2003) 1.02
Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatr Scand (2003) 1.02
Metabolic disturbance in first-episode schizophrenia. Br J Psychiatry Suppl (2004) 0.98
Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications. CNS Drugs (2001) 0.93
First-episode schizophrenia: a focus on pharmacological treatment and safety considerations. Drugs (2005) 0.91
Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia. Schizophr Res (2005) 0.91
Preventing obesity: a life cycle perspective. J Am Diet Assoc (2006) 0.89
The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. J Clin Psychopharmacol (1998) 0.84
Weight gain in first-episode psychosis. Can J Psychiatry (2003) 0.83
Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved. Acta Psychiatr Scand (2005) 0.83
Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatr Scand (1990) 0.82
Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone. Schizophr Res (2001) 0.80
Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci (2008) 6.97
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry (2005) 2.39
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord (2009) 1.90
Smartphone ownership and interest in mobile applications to monitor symptoms of mental health conditions. JMIR Mhealth Uhealth (2014) 1.74
Web-based psychoeducational intervention for persons with schizophrenia and their supporters: one-year outcomes. Psychiatr Serv (2010) 1.58
Psychological stress is associated with heightened physiological arousal during NREM sleep in primary insomnia. Behav Sleep Med (2007) 1.47
Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr Bull (2009) 1.36
Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull (2003) 1.34
Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull (2003) 1.28
A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophr Res (2008) 1.28
Cerebellar volume in offspring from multiplex alcohol dependence families. Biol Psychiatry (2006) 1.27
Biomarkers and clinical staging in psychiatry. World Psychiatry (2014) 1.22
Are older antipsychotic drugs obsolete? BMJ (2006) 1.19
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. Schizophr Bull (2014) 1.09
Short-term stability of sleep and heart rate variability in good sleepers and patients with insomnia: for some measures, one night is enough. Sleep (2012) 1.04
Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr Res (2003) 1.02
Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophr Res (2010) 1.02
Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophr Res (2003) 1.00
D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia. Neuropsychopharmacology (2007) 1.00
Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients. Schizophr Res (2009) 0.98
fMRI BOLD response to the eyes task in offspring from multiplex alcohol dependence families. Alcohol Clin Exp Res (2007) 0.98
Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia. Schizophr Res (2006) 0.98
MRI study of corpus callosum in children and adolescents with bipolar disorder. Psychiatry Res (2005) 0.95
Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophr Res (2005) 0.94
Decreased coherence in higher frequency ranges (beta and gamma) between central and frontal EEG in patients with schizophrenia: A preliminary report. Psychiatry Res (2005) 0.91
Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia. Schizophr Res (2005) 0.91
Grief and mourning in schizophrenia. Psychiatry (2007) 0.91
Evaluation of familial influences on the course and severity of schizophrenia among US and Indian cases. Soc Psychiatry Psychiatr Epidemiol (2004) 0.88
Cognitive remediation in schizophrenia. Clin Psychopharmacol Neurosci (2012) 0.88
Addressing cardiometabolic risk during treatment with antipsychotic medications. Curr Opin Psychiatry (2008) 0.88
An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.87
Development and sexual dimorphism of the pituitary gland. Life Sci (2006) 0.85
Socioeconomic status and psychological function in children with chromosome 22q11.2 deletion syndrome: implications for genetic counseling. J Genet Couns (2010) 0.85
Effect of antipsychotics on pituitary gland volume in treatment-naïve first-episode schizophrenia: a pilot study. Schizophr Res (2007) 0.85
Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST Study). Schizophr Res (2013) 0.84
Grey matter volume reductions in the emotion network of patients with depression and coronary artery disease. Psychiatry Res (2010) 0.83
Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia. Schizophr Res (2012) 0.82
Use of aripiprazole in tardive dyskinesia: an open label study of six cases. World J Biol Psychiatry (2009) 0.81
Reduced activation of superior temporal gyrus during auditory comprehension in young offspring of patients with schizophrenia. Schizophr Res (2011) 0.81
Decreased nonlinear complexity and chaos during sleep in first episode schizophrenia: a preliminary report. Schizophr Res (2004) 0.81
MRI study of thalamus volumes in juvenile patients with bipolar disorder. Depress Anxiety (2006) 0.81
The role of social media in schizophrenia: evaluating risks, benefits, and potential. Curr Opin Psychiatry (2016) 0.81
Neurobiology of mood-state shifts in bipolar disorder: a selective review and a hypothesis. Harv Rev Psychiatry (2014) 0.80
Neurological abnormalities among offspring of persons with schizophrenia: relation to premorbid psychopathology. Schizophr Res (2008) 0.80
Predictors of aripiprazole treatment continuation in hospitalized patients. J Clin Psychiatry (2008) 0.79
Adherence to Diabetes Medication in Individuals with Schizophrenia: A Systematic Review of Rates and Determinants of Adherence. Clin Schizophr Relat Psychoses (2014) 0.78
Blunted serotonergic responsivity in neuroleptic-naïve patients at first-episode of schizophrenia. Schizophr Res (2007) 0.78
Sustained gamma-band EEG following negative words in depression and schizophrenia. Int J Psychophysiol (2009) 0.78
Diabetes resolution following discontinuation of a second-generation antipsychotic. Clin Schizophr Relat Psychoses (2013) 0.78
Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary study. Diabetes Metab Syndr Obes (2012) 0.77
A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept. J Clin Psychopharmacol (2014) 0.77
Mental health of Asian American populations: Challenges and opportunities. Asian J Psychiatr (2010) 0.76
From bench to bedside: translating new research from genetics and neuroimaging into treatment development for early-onset schizophrenia. Early Interv Psychiatry (2009) 0.76
Comparison of five actigraphy scoring methods with bipolar disorder. Behav Sleep Med (2012) 0.75
Longitudinal treatment outcome of African American and Caucasian patients with first episode psychosis. Asian J Psychiatr (2011) 0.75
Cognitive remediation for individuals with psychosis in a supported education setting: a pilot study. Rehabil Res Pract (2012) 0.75
Gerard E. Hogarty (1935--2006): combining science and humanism to improve the care of persons with schizophrenia. Schizophr Bull (2007) 0.75
Dietary intake of patients with schizophrenia. Psychiatry (Edgmont) (2005) 0.75
Obituary. Asian J Psychiatr (2010) 0.75
Systematic Review of Digital Phenotyping and Machine Learning in Psychosis Spectrum Illnesses. Harv Rev Psychiatry (2020) 0.75
Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders. J Clin Psychiatry (2015) 0.75
Disaster mental health in Asia and the Asian Journal of Psychiatry. Asian J Psychiatr (2008) 0.75
Assessing online dietary information for people with schizophrenia. Psychiatr Serv (2014) 0.75
Risk factors of suicide: Need for more research in Asian populations. Asian J Psychiatr (2011) 0.75